Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Alestramustine is a cytostatic antineoplastic agent. The drug, via its active metabolites, binds to microtubule-associated proteins and β-tubulin and interferes with microtubule function, thereby suppressing cell division. Due to its estrogen moiety, Alestramustine has selectively concentrated in estrogen receptor-positive cells such as the prostate and breast.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | Alestramustine is a cytostatic antineoplastic agent. The drug, via its active metabolites, binds to microtubule-associated proteins and β-tubulin and interferes with microtubule function, thereby suppressing cell division. Due to its estrogen moiety, Alestramustine has selectively concentrated in estrogen receptor-positive cells such as the prostate and breast. |
Molecular Weight | 511.48 |
Formula | C26H36Cl2N2O4 |
CAS No. | 139402-18-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Alestramustine 139402-18-9 inhibitor inhibit